voriconazole has been researched along with Cardiac Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blot, S; Bulpa, P; Dimopoulos, G; Forêt, F; Frantzeskaki, F; Kosmopoulos, M; Taccone, FS; Van den Abeele, AM; Vogelaers, D | 1 |
| Hayashi, N; Imanishi, T; Kasagi, S; Kurimoto, C; Morinobu, A; Saegusa, J; Yamamoto, T | 1 |
| Haruki, K; Hayashi, A; Hisauchi, I; Kobayashi, S; Komatsu, T; Nakahara, S; Sakai, Y; Taguchi, I | 1 |
| Arora, HS; Bajaj, N; Chadha, D; Hasija, P | 1 |
4 other study(ies) available for voriconazole and Cardiac Diseases
| Article | Year |
|---|---|
Endomyocardial and pericardial aspergillosis in critically ill patients.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Female; Heart Diseases; Humans; Immunocompetence; Immunocompromised Host; Incidence; Invasive Fungal Infections; Lipopeptides; Male; Middle Aged; Myocardium; Pericardium; Risk Factors; Voriconazole | 2017 |
Claviform aspergillus-related vegetation in the left ventricle of a patient with systemic lupus erythematosus.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Echocardiography; Female; Heart Diseases; Heart Ventricles; Humans; Lupus Erythematosus, Systemic; Voriconazole | 2018 |
Long-Term Favorable Course of Aspergillus Endo-, Myo-, and Pericarditis.
Topics: Adult; Antifungal Agents; Aspergillosis; Heart Diseases; Humans; Male; Voriconazole | 2017 |
Invasive aspergillosis presenting as an intracardiac mass in an immunocompetent host.
Topics: Administration, Intravenous; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Echocardiography; Heart Diseases; Humans; Immunocompetence; Male; Respiratory Tract Infections; Treatment Outcome; Voriconazole; Young Adult | 2016 |